Integration of priority population, health and nutrition interventions into health systems: systematic review by Atun, Rifat et al.
RESEARCH ARTICLE Open Access
Integration of priority population, health and
nutrition interventions into health systems:
systematic review
Rifat Atun
1*, Thyra E de Jongh
1, Federica V Secci
1, Kelechi Ohiri
2, Olusoji Adeyi
2 and Josip Car
3
Abstract
Background: Objective of the study was to assess the effects of strategies to integrate targeted priority
population, health and nutrition interventions into health systems on patient health outcomes and health system
effectiveness and thus to compare integrated and non-integrated health programmes.
Methods: Systematic review using Cochrane methodology of analysing randomised trials, controlled before-and-
after and interrupted time series studies. We defined specific strategies to search PubMed, CENTRAL and the
Cochrane Effective Practice and Organisation of Care Group register, considered studies published from January
1998 until September 2008, and tracked references and citations. Two reviewers independently agreed on
eligibility, with an additional arbiter as needed, and extracted information on outcomes: primary (improved health,
financial protection, and user satisfaction) and secondary (improved population coverage, access to health services,
efficiency, and quality) using standardised, pre-piloted forms. Two reviewers in the final stage of selection jointly
assessed quality of all selected studies using the GRADE criteria.
Results: Of 8,274 citations identified 12 studies met inclusion criteria. Four studies compared the benefits of
Integrated Management of Childhood Illnesses in Tanzania and Bangladesh, showing improved care management
and higher utilisation of health facilities at no additional cost. Eight studies focused on integrated delivery of
mental health and substance abuse services in the United Kingdom and United States of America. Integrated
service delivery resulted in better clinical outcomes and greater reduction of substance abuse in specific sub-
groups of patients, with no significant difference found overall. Quality of care, patient satisfaction, and treatment
engagement were higher in integrated delivery models.
Conclusions: Targeted priority population health interventions we identified led to improved health outcomes,
quality of care, patient satisfaction and access to care. Limited evidence with inconsistent findings across varied
interventions in different settings means no general conclusions can be drawn on the benefits or disadvantages of
integrated service delivery.
Background
Benefits of integrating targeted priority population,
health and nutrition programmes into mainstream
health system functions have been the subject of a long-
standing debate, characterised by polarisation of views: a
debate recently rekindled due to substantial increases in
externally funded targeted programmes[1-3]. Further-
more, the major focus of the recent G8 summits in
Japan and Italy emphasised in developing countries
approaches that foster both health systems strengthen-
ing and disease-specific targeted approaches[4]. In spite
of this rich debate for or against integration and how it
should be achieved, however, all too frequently the argu-
ments have not been underpinned by robust consistent
evidence [1].
According to the World Health Organization (WHO),
integrated health services, also called the ‘horizontal’
approach, represent “the process of bringing together
common functions within and between organizations to
solve common problems, developing a commitment to
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and resources to achieve these goals”[5]. In 2008, WHO
re-defined integrated health services as “organization
and management of health services so that people get
the care they need, when they need it, in ways that are
user-friendly, achieve the desired results and provide
value for money”[6]. On the other hand, targeted inter-
ventions, also called the ‘vertical’ approach, refer to
delivery of health services focused on addressing a speci-
fic disease or a condition[7].
Our review is focused on priority population, health
and nutrition programmes and their integration. These
programmes, which include reproductive health, mater-
nal and child health, communicable diseases, immuniza-
tion and malnutrition,[8] represent a set of health
strategies fundamental for economic and human devel-
opment and poverty alleviation as set for example in the
Millennium Development Goals (MDGs)[9].
Health related MDGs do not include mental disorders
and mental health-related conditions (such as anxiety
disorders, alcohol and drug abuse) even though they
represent an important cause of sickness and disability
in both developed and developing countries:[10]
accounting for 40% of primary care consultations in
developed countries. Their integration has been highly
recommended, with the assumption that integration
offers the possibility of simultaneous treatment of both
mental and physical health needs[11].
The presence of both integrated and non-integrated
programmes in many countries suggests there may be
benefits to either approach, but the relative merits of
integration, in terms of improved health outcomes,
equity or efficiency, in various contexts and for different
interventions have not been systematically analysed and
documented[1]. Such an analysis is complex as integra-
tion is used to describe a variety of organisational
arrangements in relation to key health system functions
[12]. Furthermore, as the nature and extent of integra-
tion of targeted interventions into mainstream health
system functions vary, there are methodological chal-
lenges to comparing various interventions.
We conducted a systematic review to assess the effects
of strategies to integrate targeted priority population,
health and nutrition interventions into mainstream
health system delivery on patient health outcomes and
effectiveness of health systems and thus compared inte-
grated and non-integrated health programmes.
Methods
We followed the Cochrane methodology for conducting
systematic reviews[13]. Study designs considered for
inclusion comprised randomised controlled trials (RCT),
controlled clinical trials (CCT), interrupted time series
(ITS), and controlled before and after studies (CBA).
Our search algorithm was designed to include a wide
range of health interventions and study settings, with no
limit on type of study participants.
We included interventions focused on improving inte-
gration of priority population, health and nutrition pro-
grammes. Interventions focused on health care
integration improvement refer to changes in organisa-
tion, management, planning and decision making in
health care resulting in delivery of a range of services at
a particular service delivery point, in provision of pre-
ventive and curative health care to a particular group of
patients and in continuity of health care over time.
These interventions were confined to priority popula-
tion, health and nutrition programmes, i.e. reproductive
health, maternal and child health, communicable dis-
eases, immunization, malnutrition, mental health disor-
ders and substance abuse.
We carefully defined, with the help of an information
specialist, the databases that would likely yield relevant
studies and specific strategies to search PubMed, the
Cochrane Central Register of Controlled Trials (CEN-
TRAL), the Cochrane Effective Practice and Organisa-
tion of Care Group (EPOC) register and Database of
Abstracts of Reviews of Effectiveness.
The search strategy is detailed in Additional file 1. We
also screened reference lists of the included studies and
citations i.e. all references that cited any of the included
studies identified using the ISI Science and Social
Science Citation Index. We searched for studies pub-
lished from January 1998 until September 2008. The
search was limited to articles in English.
Given the wide variety of countries and care settings
considered in this review, we anticipated substantial het-
erogeneity in utilised outcome measures and hence
included in the review all outcome measures of interest.
Primary outcome measures of interest were changes in
health status (for instance changes in incidence, preva-
lence, mortality and morbidity rates or composite
indices), financial protection, and user satisfaction. Sec-
ondary outcome measures included population coverage,
equity, efficiency (for example changes in cost, cost-
effectiveness), and quality (for example, adherence to
guidelines for prevention, treatment and care).
Two reviewers (TdJ, FVS) independently performed
the initial selection of studies by scanning the titles of
all the retrieved references against inclusion and exclu-
sion criteria based on relevance and scope of study
(health, nutrition, population interventions; details avail-
able from authors on request). Each reviewer indepen-
dently assessed 60% of the titles, with a high degree of
inter-rater agreement as measured by Cohen’s  coeffi-
cient of 0.78. Both reviewers subsequently assessed for
relevance all abstracts independently that passed the
first phase. In case of disagreement between the
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Both reviewers then assessed full text articles of all
potentially relevant studies. A third senior reviewer
resolved disagreements (RA). Two reviewers (TdJ, FVS)
in the final stage of selection jointly assessed quality of
all selected studies using the Cochrane EPOC group cri-
teria. A third reviewer (RA) then appraised the selected
studies and confirmed their suitability for inclusion.
Only studies that presented low or moderate risk of bias
were included in the review.
We extracted data concerning the details of study
characteristics (design, quality, randomisation, alloca-
tion), setting, intervention, participants, and outcomes
(primary and secondary) using a purposely-designed
data extraction sheet.
We divided the studies into two main sets based on
type of intervention and care setting. Within each set
we collected and compared all primary and secondary
outcomes of interest. Due to the high level of heteroge-
neity of the evidence both within and between sets, no
meta-analysis of results could be performed. We
assessed the strength of the evidence for each type of
outcome for the consistency of findings across studies,
the directness of the evidence and the possible impact
of confounding variables using the GRADE quality cri-
teria[14,15].
Results
Description of the studies
We retrieved from the database search 8,274 potentially
relevant articles (Figure 1). After screening titles for
relevance we selected 1,551 titles for the next stage.
Screening of abstracts by both reviewers for relevance
and study design reduced the selection to 88 potentially
suitable studies (Cohen’s  coefficient for inter-rater
agreement 0.78). An analysis of the full text resulted in
the exclusion of 62 more studies. We retrieved and
included one additional study by reference tracking.
After quality appraisal ten studies met the inclusion cri-
teria. Five of the included studies presented low risk of
bias and five moderate risk of bias (Additional file 2).
Eight studies were randomised controlled trials,[16-22]
and two were controlled before and after studies[23,24].
We included two additional studies as supplementary
data to one of the included controlled before and after
studies (Armstrong Schellenberg 2004) and relied on the
same data set (Additional file 3)[23,25,26].
Geographic location of the studies
Four of the ten studies examined implementation of the
Integrated Management of Childhood Illnesses (IMCI)
strategy in developing countries,[17,23,25,26] and the
remaining eight studies analysed provision of mental
health and/or substance abuse services in developed
countries, notably the United States of America (USA)
and the United Kingdom (UK). Within the latter group
there were three distinct series of studies (Table 1): the
first refers to the PRISM-E project in the USA in which
integrated delivery of mental health or substance abuse
services for elderly veterans in a primary care setting
was piloted;[16,19,20] the second, from the US, focused
on integration of substance abuse treatment and medical
care services for patients with addiction problems and
associated co-morbidities;[21,22] and the third group of
studies from the US and the UK analysed the impact of
integrating treatment of schizophrenia and depression
respectively into primary health care[18,24,27].
Types of interventions
We distinguished two main groups of studies. The first
group compared IMCI with ‘routine care’ comprising
separate distinct programmes for managing childhood ill-
ness[17,23,25,26]. The second group compared mental
health and/or substance abuse treatment services inte-
grated into primary health care or with specialist commu-
nity teams with ‘routine’ mental health services including
those provided in hospitals, and substance abuse treat-
ments delivered as stand alone specialist services with no
integration to primary health care or other services deliv-
ered in the community[16,18-22,24,27]. Figure 2 illustrates
conceptually potential integration strategies within and
across primary, community and secondary care domains.
Findings from the studies
Integrated Management of Childhood Illnesses
IMCI is a systematic approach to children’sh e a l t h ,
which focuses on the child as a whole, rather than on a
single disease or condition. The approach, developed by
WHO and UNICEF, aims to reduce death, illness and
disability, and promote improved growth and develop-
ment among children under five years of age. Its imple-
mentation emphasises the use of clinical guidelines
adapted to a country context. The IMCI strategy stres-
ses coordinated activities within three components
aimed at improving: (1) the performance of health work-
ers in the prevention and treatment of childhood dis-
eases; (2) the organisation and operation of health
services so they provide quality care; and (3) family and
community care practices (e.g. appropriate care seeking
behaviour or improved nutrition). IMCI focuses on both
prevention and treatment implemented by families and
communities as well as by healthcare providers. Chil-
dren brought for medical treatment in the developing
world are often suffering from more than one condition,
making a single diagnosis difficult. IMCI ensures the
combined treatment of the major childhood illnesses,
emphasizing prevention of disease through immuniza-
tion and improved nutrition.
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controlled before-and-after study to compare child
health and survival as well as economic costs and bene-
fits between two rural districts where IMCI had been
implemented for two years prior to the evaluation with
two neighbouring control districts that used routine
care comprising disease-specific approaches but not
IMCI[23]. The study districts had comparable geo-
graphic, demographic and mortality profiles at the time
of introduction of IMCI.
References resulting from searches n=8,274 
References retained for evaluation of 
abstracts n=1,551 
References retained for evaluation of full text 
n=88 
References retained for quality appraisal 
based on Cochrane EPOC criteria n=26 
References excluded after screening of title
for relevance n=6,723 
References excluded after screening of 
abstracts for relevance and study design 
n=1,463 
References excluded after screening of full 
text for relevance and study design n=62 
Studies retained for inclusion in the review 
n=12 (8 RCT, 2 CBA, 2 supplementary 
studies) 
References excluded based on failure to 
meet quality criteria n=15 
Reference tracking n=1 
Figure 1 Flow chart of the study selection process.
Table 1 Classification of included studies
Programme classification Studies Description of intervention
Integrated Management of Childhood Illnesses (IMCI) El Arifeen 2004
Armstrong
Schellenberg
2004
Integration based on treatment guidelines and training for
management of childhood illnesses
The Primary Care Research in Substance Abuse and
Mental Health for the Elderly study (PRISM-E)
Bartels 2004
Krahn 2006
Oslin 2006
Integrated delivery of mental health and/or substance abuse services
for elderly veterans in a primary care setting
Services for substance abuse and primary medical care Weisner 2001
Willenbring 1999
Substance abuse treatment integrated with medical treatment of
substance abuse-related co-morbidities
Mental health services in primary health care Gater 1997
Watts 2007
Druss 2001
Treatment services for depression, schizophrenia and other mental
illness integrated into primary health care
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improved for a number of measures for correct diagno-
sis and treatment (Table 2). Furthermore, the under-5
mortality rate was 13% lower in IMCI districts than in
comparison areas. Prevention behaviours, such as use of
mosquito nets, all favoured the comparison districts.
Care seeking behaviour appeared unaffected under
IMCI, whereas knowledge of caregivers on correct use
of oral rehydration salts significantly improved. Two
related studies found that implementation of IMCI was
not more costly than routine care,[25] and led to signifi-
cant improvements in case management at costs similar
to or lower than those of conventional case-manage-
ment[26].
In Bangladesh, a cluster-randomised controlled trial
compared 20 randomly selected facilities in which
nationally adapted IMCI case management guidelines
were introduced with 20 paired facilities that had not
implemented the guidelines[17]. The quality of care (as
measured by adherence to IMCI guidelines), care-seek-
ing behaviour and utilization of governmental health
facilities had all improved 18 months after introduction
of IMCI.
Integrating substance abuse treatment for patients with
substance abuse-related conditions
We found two studies focused on integration of addic-
tion treatment programmes. Both studies compared the
integrated management of substance abuse treatment
and medical care of substance abuse-related co-morbid-
ities with independent, routine treatment approaches
where addiction treatment was provided separately from
comprehensive medical care.
Weisner et al. (2001) conducted a randomised con-
trolled trial in Sacramento, US, to compare the effective-
ness, service utilization and treatment costs of a
substance abuse programme in which primary health
care services were integrated within the treatment unit
with a control programme in which patients received
the same set of substance abuse services but where
medical care was provided in separate primary care
clinics[21]. The 285 patients randomly assigned to the
intervention arm included 169 patients with substance
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Figure 2 Conceptual diagram of the different models of integration reviewed in the study.
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Page 5 of 10abuse-related medical conditions (SAMC) and 116
patients with a substance abuse problem but no asso-
ciated medical conditions (non-SAMC). The study
found no differences in total, alcohol, and other drug
abstinence rates for the non-SAMC patients (Table 3).
However, patients with medical or psychiatric SAMCs
who received integrated care had higher total and alco-
hol abstinence rates and longer periods of abstinence
without a significant increase in average cost of all treat-
ment per month.
A randomised controlled trial by Willenbring et al.
(1999) in Minneapolis, USA compared veterans (n = 48)
with a diagnosis of severe alcohol-related medical illness
who received Integrated Outpatient Treatment (IOT) for
medical problems and alcoholism through a single referral
appointment at the Minneapolis Veterans Affairs Medical
Centre (MVAMC) with a control group (n = 53) that
received routine care comprising outpatient medical ser-
vices in the medical and specialty medicine clinics of the
MVAMC[22]. The intervention group was simultaneously
evaluated for alcoholism and, if needed, recommended for
alcoholism treatment at an independent treatment facility.
The integrated care led to higher patient engagement
compared with routine care (Table 3). The average num-
ber of IOT visits for patients in the integrated model gra-
dually decreased, in contrast to the control group where
the number of visits did not change. Abstinence rates after
two years were significant in both study arms, but higher
in the group receiving IOT. The effect on two-year survi-
val was statistically not significant.
Integrating mental health services in primary care
The Primary Care Research in Substance Abuse and
Mental Health for the Elderly study (PRISM-E), a multi-
site randomised controlled trial (RCT), compared an
integrated model of mental health and substance abuse
services in primary health care with an enhanced refer-
ral model (i.e. services in a specialised mental health/
substance abuse clinic, physically separate from the pri-
mary health care unit)[16,19,20]. The study, conducted
in five Department of Veteran Affairs (VA) Medical
Centres, three community health centres and two outpa-
tient hospital networks, compared service use, clinical
outcomes and costs of service delivery for older people
with depression, anxiety or at-risk alcohol consumption.
In 9 out of 10 settings, there were more mental health
and substance abuse visits and higher appointment
attendance in the integrated care model for all demo-
graphic and diagnostic groups (Table 3)[16]. For
patients suffering depression, depression severity
declined and mental functioning improved in both mod-
els. No significant differences were found, except for
patients with major depression for whom the enhanced
referral model produced better symptomatic outcomes
[19]. For older patients with at-risk alcohol consumption
behaviour, there were reductions in both the quantity
and frequency of drinking and binge drinking in both
treatment modalities. However, no statistically signifi-
cant differences were found on either measure between
the two treatment models[20].
Watts et al. (2007) conducted a retrospective before-
and-after study in Vermont (USA) to assess the quality
of care and access to treatment for patients diagnosed
with depression and treated in a primary mental health
clinic [PMHC] at a Veteran Affairs medical centre con-
sisting of open access mental health services co-located
in a primary health care clinic but with no new staff
Table 2 Outcomes for studies on IMCI
Type of
outcome
Study Measure Outcome (IMCI vs. Control area)
Health
outcomes
Armstrong
Schellenberg 2005
Death rate per 1000 child years. From 27.2 to 24.4 vs. from 27.0 to 28.2, (p = 0.28)
Carer of child prescribed oral medication reports
correctly how to give treatment.
163/225 (72%) vs. 100/179 (56%), (p = 0.02)
Quality of
care
Armstrong
Schellenberg 2005
Children checked for presence of cough, diarrhoea
and fever.
219/231 (95%) vs. 67/188 (36%), (p < 0.0001)
Children correctly classified. 139/219 (63%) vs. 66/176 (38%), (p < 0.0001)
Correct prescription of oral antibiotics and/or oral
anti-malarials.
159/219 (73%) vs. 63/178 (35%), (p < 0.0001)
El-Arifeen 2004 Mean index of correct treatment and counselling. From 8 to 54 vs. from 5 to 9, (p < 0.001)
Utilisation of
services
Armstrong
Schellenberg 2005
Change in appropriate care seeking behaviour. From 211/512 (41%) to 203/531 (38%) vs. from 209/502
(42%) to 138/427 (30%), (p = 0.45)
El-Arifeen 2004 Ill children taken to a health facility or health
worker.
From 10% to 19% vs. from 6% to 9%
Cost Adam 2005 Annualised cost of care. US$ 11.19 vs. US$ 16.09
Bryce 2005 Cost per child visit managed correctly. US$ 4.02 vs. US$ 25.70
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Type of
outcome
Study Measure Outcome (Intervention vs. Control)
Health
outcomes
Druss 2001 Change in physical component summary index. +4.7% vs. -0.3%, (p < 0.001)
Change in mental component summary index. +2.4% vs. +2%, (p = 0.84)
Krahn 2006 Change in Centre for Epidemiological Studies
Depression scale (CES-D) score.
Patients with all depression:
-6.0 ± 12.0 vs. -7.8 ± 11.8, (p = 0.07)
Patients with major depression:
-7.5 ± 13.1 vs. -10.2 ± 12.1, (p = 0.003)
Change in Medical Component Score (MCS). Patients with all depression:
+4.8 ± 12.6 vs. +4.9 ± 12.9, (p = 0.88)
Patients with major depression:
+5.9 ± 12.6 vs. + 6.8 ± 12.8, (p = 0.32)
Willenbring
1999
Number of patients with 2-year survival. 31/38 (81%) vs. 26/37 (70%), (p = 0.03)
Drug and
alcohol
use
Oslin 2006 Change in number of drinks per week. -6.0 vs. -5.9 (p = 0.913)
Change in number of binge episodes in the
preceding three months.
-8.5 vs. -10.2 (p = 0.750)
Weisner
2001
Total abstinence and duration of abstinence. Non-SAMC patients:
66% vs. 73%, (p = 0.23)
SAMC patients:
69% vs. 55%, (p = 0.006); period of abstinence 135 days vs. 122 days,
(p = 0.05)
Alcohol abstinence. Non-SAMC patients:
73% vs. 78% (p = 0.41)
SAMC patients:
80% vs. 65%, (p = 0.002)
Other drug abstinence Non-SAMC patients:
84% vs. 87%, (p = 0.50)
Willenbring
1999
Number of patients with alcohol abstinence after
2 years.
28/38 (74%) vs. 17/36 (48%), (p = 0.02)
Patient
satisfaction
Druss 2001 Satisfaction score on 47-item questionnaire. Patients in integrated model were more satisfied with overall care
received in 6 of 8 domains (access, attention to patient preferences,
courtesy, coordination, continuity, and overall care) (p < 0.05 on all 6
domains)
Gater 1997 Score on Client Satisfaction Questionnaire (range
1-4; low score indicates higher satisfaction).
1.86 vs. 2.23
Quality of
care
Druss 2001 Delivery of preventive measures outlined in
clinical guidelines.
Patients in integrated model (n = 59) more likely than in control
group (n = 61) to receive 15 of 17 measures, (p < 0.01)
Gater 1997 Number of clinical needs met; and unmet. 2.62 vs. 1.60, (p < 0.001);
0.57 vs. 1.62 (p < 0.001)
Number of social needs met; and unmet. 1.83 vs. 1.49, (p = NS); 0.86 vs. 1.64 (p < 0.05)
Watts 2007 Patients who screened positive for depression
and received treatment in accordance with
guidelines.
From 1.1% to 11.2% vs. from 3.0% to 0.7%, (p < 0.001)
Utilisation
of services
Bartels 2004 Mean number of mental health and substance
abuse visits.
3.04 vs. 1.91 (p ≤ 0.001)
Appointment attendance. 71% vs. 48.8% (95% CI = 2.14 to 3.08)
Druss 2001 Patients who used a medical: Primary care
service; Specialty service;
Emergency department;
Inpatient service.
54/59 (91.5%) vs. 44/61 (72.1%), (p = 0.006);
41/59 (69.5%) vs. 41/61 (67.2%), (p = 0.17);
7/59 (11.9%) vs. 16/61 (26.2%), (p = 0.04);
5/59 (8.5%) vs. 11/61 (18%), (p = 0.12)
Patients who used a mental health:
Outpatient service; Emergency department;
Inpatient service.
58/59 (98.3%) vs. 61/61 (100%), (p = 0.31);
21/59 (35.6%) vs. 25/61 (41%), (p = 0.31);
8/59 (13.6%) vs. 10/61 (16.4%), (p = 0.66)
Willenbring
1999
Mean number of IOT visits in 2 years. 42.2 ± 29.1 vs. 17.4 ± 15.6, (p < 0.001)
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munity-based outreach clinics associated with primary
health care and mental health clinics at the VA medical
centre)[24]. The percentage of patients who screened
positive for depression and received optimal treatment
in accordance with guidelines increased at the interven-
tion facility but declined at the control sites (Table 3).
Substantially more patients who screened positive were
able to access mental health services in the PMHC
model and received treatment sooner than the commu-
nity-based clinics.
An RCT was conducted by Gater et al. (1997) to
assess the quality and cost of care provided to schizo-
phrenic patients by general practitioners linked to a new
specialist community team compared to general practi-
tioners who used the usual hospital-based service[18].
Patients treated by the new community team were more
satisfied with their care and reported fewer unmet needs
than patients referred to specialist hospital psychiatric
units (Table 3). Better quality of care was maintained in
the community team model four years after its introduc-
tion. Cost differences between the two models of care
were not significant.
Druss et al. (2001) used an RCT to compare a model
that provided integrated medical and mental health ser-
vices in a primary care setting for older patients with ser-
ious mental health disorders, to a routine care model in
which primary care is provided by a VA general medicine
clinic after referral from a mental health clinic[27]. The
intervention was associated with greater access to pri-
mary and preventive care, and bigger improvements in
service quality, user satisfaction, and health related qual-
ity of life, at no significant difference in cost (Table 3).
Analysis on the basis of the GRADE statement showed
high quality of evidence that IMCI strategies reduced
under-5 mortality and moderate quality of evidence that
IMCI improves the quality of care. As for the mixed
impact that IMCI had on utilisation of health services,
we judged the quality of evidence as low (Annex 3, A).
Evidence grading on studies of integrated delivery of
mental health and/or substance abuse treatment services
showed that there was a moderate quality of evidence
that the quality of care and patient satisfaction improved
under integrated models of care and a low quality of
evidence that integrated health services improved treat-
ment engagement and access to mental health services.
The quality of evidence which suggested no difference
in health care outcomes and that for 2-year survival
across care models was also graded as moderate (Annex
3, B).
Discussion
Our systematic review shows that evidence on the rela-
tive benefits of integration of priority population, health
and nutrition interventions (i.e. targeted versus inte-
grated delivery of health services) is limited and too
weak to allow for clear conclusions about when either
approach is desirable. The limited evidence available
suggests that integrated approaches to delivering health
services, compared with targeted unintegrated
approaches, improve outcomes in selected areas. It is
critical that this important question receives the atten-
tion of researchers that it deserves and that we move
beyond the experts’ information, viewpoints and concep-
tual frameworks guiding billions of dollars invested in
priority population, health and nutrition interventions.
Studies assessing the implementation of the IMCI pro-
gramme in developing countries illustrated that integra-
tion based on implementation of case management
guidelines improved quality and utilization of health
care with no significant increase in cost delivery
[17,23,25,26]. Results of eight eligible studies from devel-
oped countries (USA and UK) that analysed integration
of service delivery for mental health disorders and sub-
stance abuse into community or primary health care are
more complex. Nevertheless, integrated management of
substance abuse treatment and substance abuse-related
co-morbidities health care resulted in higher abstinence
rates compared to standard treatment approaches where
addiction treatment was provided separately from com-
prehensive medical care[21,22]. Studies evaluating inte-
grated models of mental health in primary health care
demonstrated advantages of integration[16,18-20,24,27].
The key benefits of integrated models of service deliv-
ery in this review were improved quality of care and
clinical outcomes,[17,18,21-24,26,27] greater treatment
Table 3 Outcomes for studies on integrated delivery of mental health and substance abuse services (Continued)
Mean number of IOT visits in first and last 6
months of treatment.
From 14 to 9 vs. 4-6 in both periods
Access to
health care
Watts 2007 Patients who screened positive and were able to
access mental health services.
36.0% vs. 9%, (p < 0.001)
Cost Druss 2001 Mean cost per subject treated US$ 13,010 vs. US$ 14,543
Gater 1997 Overall per capita health service cost £ 1,406 vs. £ 1,199
Weisner
2001
Average cost of all treatment per month US$ 470.81 vs. US$ 427.95, (p = 0.14)
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or difficult to reach in more conventional care models,
[16,19,22,24,27] and improved patient satisfaction and
targeting of resources[18,27].
I ti s ,h o w e v e r ,i m p o r t a n tt on o t et h a te v e ni nt h e s e
studies these benefits do not always accrue to all
patients treated under the integrated care model.
Whereas Weisner et al. (2001) found no benefits for
integrated delivery of substance abuse treatment and
medical services in patients without substance abuse-
related co-morbidities,[21] Krahn et al. (2006) demon-
strated that the enhanced referral model produced bet-
ter symptomatic outcomes for patients with major
depression than the integrated model did, possibly due
to better access to more specialised psychiatric and
medication management services[19].
Although the quality of the evidence from the included
studies was rated as moderate to high according to
GRADE appraisal and demonstrated various benefits of
integrated health care programmes, these findings cannot
be generalized. Evaluated interventions as well as the
definitions of integration of health care programmes
across the studies included in our review were very het-
erogeneous. Furthermore, care setting, participants, inter-
ventions used as controls and types of outcomes all
differed significantly and therefore do not allow us to
form an overall conclusion on the effectiveness of inte-
grated health programmes. In practice most health ser-
vices combine non-integrated and integrated elements,
but the balance between programmes in these elements
varies considerably and is rarely clearly spelled out even
in a research context. Hence, when programme designs
are being researched, more clarity is needed on the pro-
gramme element being referred to: e.g. governance
arrangements, organisation, funding and service delivery.
Conclusions
In contrast to the systematic review by Briggs et al.
(2006) on strategies for integrating primary health ser-
vices in middle- and low-income countries at the point
of delivery we included in our review studies from all
countries regardless of income[28]. While this increased
heterogeneity it provided additional valuable information
for policymakers who often have to make decisions that
encompass different settings and conditions. Our review
provides important new evidence from studies in devel-
oped countries but does not significantly change the
findings of Briggs et al. (2006) that there are few rigor-
ous studies exploring the relative merits of integrating
or not integrating programmes that emphasize specific
interventions[28].
Given the paucity of evidence, we suggest that in
order to deliver an evidence-based conclusion on effec-
tiveness of health programme integration, investments
should be made in studies with robust designs, where
possible comparable control and intervention groups, a
clear and comprehensive definition of integration, valid
and reliable outcomes and analysis of costs. These stu-
dies should be longitudinal in nature, carried out over a
period of few years so that sustainability and long term
impacts of horizontal approach could also be evaluated.
Such studies will also need to take account of the multi-
ple dimensions of integration, the wider health system
context and the political economy in which they are set
as these factors work beyond the interventions to deter-
mine the success of the programmes[12].
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